Truist Financial raised its price objective and issued a buy rating for Elevance Health, Inc. on July 4, 2026.
1 report, 1 independent
Updated Jul 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial raised its price objective and issued a buy rating for Elevance Health, Inc. on July 4, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
-
Elevance Health, Inc.
American healthcare company
Nothing else this week.
Related events
- Truist Financial raised its target price and gave a 'buy' rating for CVS Health.
- Morgan Stanley and Raymond James Financial raised their price objectives for Elevance Health, Inc. on September 15, 2026.
- Truist Financial issued a 'buy' rating and lifted the price objective for James Hardie on August 18, 2026.
- Truist Financial and Citigroup provided buy ratings and price objectives for Crown stock.
- Truist Financial and Leerink Partners raised price objectives for Eli Lilly and Company stock.